key: cord-0835947-p5fat7qt authors: Hassan, Sk. Sarif; Lundstrom, Kenneth; Barh, Debmalya; Silva, Raner Jośe Santana; Andrade, Bruno Silva; Azevedo, Vasco; Choudhury, Pabitra Pal; Palu, Giorgio; Uhal, Bruce D.; Kandimalla, Ramesh; Seyran, Murat; Lal, Amos; Sherchan, Samendra P.; Azad, Gajendra Kumar; Aljabali, Alaa A.A.; Brufsky, Adam M.; Serrano-Aroca, Ángel; Adadi, Parise; El-Aziz, Tarek Mohamed Abd; Redwan, Elrashdy M.; Takayama, Kazuo; Rezaei, Nima; Tambuwala, Murtaza; Uversky, Vladimir N. title: Implications derived from S-protein variants of SARS-CoV-2 from six continents date: 2021-09-24 journal: Int J Biol Macromol DOI: 10.1016/j.ijbiomac.2021.09.080 sha: f11e370c040e4852e352dcea9cde41839bb54ef1 doc_id: 835947 cord_uid: p5fat7qt Spike (S) protein is a critical determinant of the infectivity and antigenicity of SARS-CoV-2. Several mutations in the spike protein of SARS-CoV-2 have already been detected, and their effect in immune system evasion and enhanced transmission as a cause of increased morbidity and mortality are being investigated. From pathogenic and epidemiological perspectives, spike proteins are of prime interest to researchers. This study focused on the unique variants of S proteins from six continents: Asia, Africa, Europe, Oceania, South America, and North America. In comparison to the other five continents, Africa had the highest percentage of unique S proteins (29.1%). The phylogenetic relationship implies that unique S proteins from North America are significantly different from those of the other five continents. They are most likely to spread to the other geographic locations through international travel or naturally by emerging mutations. It is suggested that restriction of international travel should be considered, and massive vaccination as an utmost measure to combat the spread of COVID-19 pandemic. It is also further suggested that the efficacy of existing vaccines and future vaccine development must be reviewed with careful scrutiny, and if needed, further re-engineered based on requirements dictated by new emerging S protein variants. variability of S1 (and its isoelectric points) as this may modulate the affinity of binding [12] . The importance of antibody avidity for protection towards SARS-CoV-2 (and other viruses) has been recently reviewed [12] . From the beginning of the second wave of COVID-19 infection, various SARS-CoV-2 variants emerged raising concern of enhanced transmission and mortality of the virus and reduced efficacy of vaccine protection [13, 14] . Some of the studies opposed the perception of SARS-CoV-2 mutations as distinctive pathogenic variants and increased rate of transmissibility were questioned [15, 16] . However, the frequency of the mutant strains within the SARS-CoV-2 population carrying the D614G mutation in the spike protein clearly plays a role in enabling the virus to spread more effectively and rapidly [17] . Epidemiologists have been constantly monitoring the evolution of SARS-CoV-2 with a particular focus on the spike protein and other interacting proteins of the virus [17, 18] . The D614G mutation in the S protein discovered in early 2020 makes the virus able to spread more effectively and rapidly [19] . The D614G mutation has been found to be related with high viral loads in infected patients, and high rate of infections, but not with increased disease severity [20] . Various mutations in the S protein make the SARS-CoV-2 more complex and hence it is more difficult to characterize its severity, infectivity and efficacy of vaccines designed to target S protein. Not all mutations are advantageous to the virus but several mutations or a set of mutations may increase the transmission potential through an increase in receptor binding or the ability to evade the host immune response by altering the surface structures recognized by antibodies [21, 22, 23] . To contain the spread of the COVID-19, it is definitely of high interest to detect and identify various unique emerging variants of S proteins. Additionally, it is also worth investigating the impact of new S protein variants on viral infectivity and potential to spread rapidly as well as to ascertain the origin of the spread of the new variants concerning spike protein variabilities. Accordingly, it might be possible to segregate the set of new variants with respect to individual characteristics of SARS-CoV-2, which would undoubtedly help policy makers to form various strategies to contain the spread of the virus. There are a large number of different SARS-CoV-2 S protein mutant sequences currently available in the NCBI virus database. In this study, all available S protein sequences from six continents Asia, Africa, Europe, North America, South America, and Oceania were analyzed for their uniqueness and variability. An inter-linkage was made among the unique S proteins available on the six continents. S protein sequences from all six continents (Asia, Africa, Europe, Oceania, South America, and North America) were downloaded in FASTA format from the National Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov/). Further, FASTA files were processed in Matlab-2021a for extracting unique S protein sequences for each continent. To filter sequences with low quality (unknown amino acids 'X') and remove redundant sequences, the SeqKit tool was used, with the tools fx2tab and rmdup respectively [24] . The filter removed all sequences that had one or more 'X' and all redundant sequences (100% identical). The amino acid sequences were aligned using the MegaX program with MUSCLE algorithm, and after it was performed a phylogeny calculation with the Neighbor-joining method, considering 3919 taxa sequences and 530 sites [25, 26] . The alignment was used as input in Archeopteryx 0.9914 with the multiple alignment inference option, following the parameters of maximum allowed gaps ratio 0.5, minimum allowed non-gap sequence length 50 and distance calculator Kimura correction [27] . The phylogenetic trees were analyzed and edited in the Archeopteryx 0.9914 tool. Any protein sequence is composed of twenty different amino acids with various frequencies starting from zero. The ability of occurrence of each amino acid Ai is determined by the formula ( ) where f(A i ) denotes the frequency of occurrence of the amino acid A i in a primary sequence, and l stands as the length of an S protein [28] . Hence for each S protein, a twenty-dimensional vector considering the frequency probability of twenty amino acids can be obtained. Based on this frequency probability, the dominance of amino acid density in a given protein is illuminated. The variability of the amino acid compositions of the unique S-proteins from each continent was evaluated using the web-based tool Composition Profiler (http://www.cprofiler.org/) that automates detection of enrichment or depletion patterns of individual amino acids or groups of amino acids in query proteins [29] . In this analysis, we used sets of unique S-proteins from each continent as query samples and the amino acid of the original S-protein (UniProt ID: P0DTC2) as a reference sample that provides the background amino acid distribution. Composition profiler generates a bar chart composed of twenty data points (one for each amino acid), where bar heights indicate normalized enrichment or depletion of a given residue. The normalized enrichment/depletion is calculated as − where C continent is the content of given residue in the query set of S-proteins in a given continent and C original is the content of the same residue in the original S-protein. For comparison, we generated composition profile of disordered proteins, where normalized composition was evaluated as − (C DisProt is content of a given amino acid in the set of intrinsically isordered proteins in the DisProt database [30] ; C PDB is content of the given residue in the dataset of fully ordered proteins, PDB-Select-25 [29] ). In these analyses, the positive and negative values produced in the compositional profiler indicated enrichment or depletion of the indicated residue, respectively. How conserved/disordered the amino acids are organized over S protein is addressed by the information-theoretic measure known as 'Shannon entropy' (SE). For each S protein, Shannon entropy of amino acid conservation over the amino acid sequence of S protein is computed using the following formula [31, 32] : For a given amino acid sequence of length l, the conservation of amino acids is calculated as follows: = ; k i represents the number of occurrences of an amino acid s i in the given sequence [33] . The isoelectric point (pI), is the pH at which a molecule carries no net electrical charge or is electrically neutral in the statistical mean. We calculate the theoretical pI by using the pKa's of amino acids and summing the net charge across the protein at a given pH (default is typical intracellular pH 7.2), searching with our algorithm for the pH at which the net charge is zero [34] . The isoelectric point is a powerful tool to predict and understand interactions between proteins, proteins and membranes or to determine the presence of protein isoforms [35] . Furthermore, it is noted that the isoelectric point is one of the prime keys for understanding a variety of biochemical properties of protein sequences [35, 36] . Note that the isoelectric point of a protein sequence was computed here using the standard routine of Matlab-2021a. This parameter was deployed to characterize the unique S protein sequences, quantitatively. Intrinsic disorder predisposition of S protein from the original (Wuhan) version of SARS-CoV-2 was analyzed by a set of six commonly used disorder predictors, such as PONDR ® VLXT, PONDR ® VL3, PONDR ® VSL2B, PONDR ® FIT, IUPred2 (Short) and IUPred2 (Long), which were selected for their specific features. The outputs of the evaluation of the perresidue disorder propensity by these tools are represented as real numbers between 1 (ideal prediction of disorder) and 0 (ideal prediction of order) [37, 38, 39, 40, 41] . Thresholds of ≥ 0.15 and ≥ 0.5 were used to identify flexible and disordered residues and regions. Intrinsic disorder profile of this protein was generated by DiSpi/RIDAO web-crawler that combines the outputs of PONDR ® VLXT, PONDR ® VL3, PONDR ® VLS2B, PONDR ® FIT, IUPred2 (Short) and IUPred2 (Long) on the one plot and complement them by the errors evaluated for mean disorder profile calculated by averaging profiles of individual predictors. Analysis of intrinsic disorder predisposition of unique variants of S protein was conducted by PONDR ® VSL2B. This tool is commonly used in the analysis of disorder predisposition of proteins and systematically shows good performance in various comparative analyses, including the recently conducted Critical assessment of protein intrinsic disorder prediction (CAID) experiment, where PONDR ® VLS2B was recognized as predictor #3 of the 43 evaluated methods [42] . We first determined the set of unique S protein sequences from each continent. Further, every unique S protein from a continent was compared with other unique S proteins from five continents, and the lists of the same are presented in Tables 12-17 . Also, the variability of the S proteins from each continent was shown using Shannon entropy and isoelectric point. In Table 1 , the number of total sequences, unique sequences and percentages are presented. Note that, a complete list of unique S protein accessions and their names (continentwise) were made available in supplementary file-1. Note that, sequence accession is renamed as Ck where C stands for continent code (Asia:AS, Africa:AF, Oceania:O, Europe:U, South America:SA, and North America:NA), and k denotes the serial number. The highest percentage (29.065%) of unique S proteins were found in Africa though the total number of available sequences is significantly low as compared with that from other continents. Almost similar amounts (in percentage) of unique S sequence variations were found in Asia and Europe. Among the total 127760 S proteins embedded in SARS-CoV-2 genomes, only 16143 (12%) unique S proteins were detected so far, and notably most of the unique variants (87%) were found in North America only. For each continent, the unique spike (S) proteins were matched with other unique proteins from the rest of the five continents, and a total number of such identical pairs are presented accordingly in the matrix ( Table 2 ). From Table 2 , it was observed that, in each continent there is still a significant percentage of unique spike variations available, which are not shared with any rest of the continents. Such percentages of unique variations of S proteins in Asia, Africa, Europe, Oceania, South America, and North America were 41%, 55%, 28%, 92%, 7%, and 97% respectively. The lists of pairs of identical S proteins of SARS-CoV-2 originating from six continents are presented in Tables 9-11 (See Appendix ). The lists of unique S proteins (from a particular continent), which were found to be identical with some unique spike proteins from other five continents, are presented in Tables (12-17 The frequency and percentage of invariant residue positions, where no amino acid change was detected so far in the unique S proteins available in each continent, are presented in Table 3 . The highest number of mutations (lowest number of invariant residue position, 6.99%) ( Table 3) were detected in the unique S proteins from North America where 12.42% unique S protein sequences were present as mentioned in Table 1 . Likewise, the lowest number (15.95%) of mutations in unique S proteins were observed in South America where 15.3% unique S sequences were found. Only 29.14% residues of 1273 in the unique S proteins were mutated, although a significantly higher number (29.065%) of unique sequences were found in Africa among the other five continents. The unique S proteins from Europe possessed only 25.5% mutations, whereas 45.5% mutations were detected in the unique S proteins from Asia although the same percentage (18.5%) of unique spike proteins were found (Tables 1 and 3) . Further it was observed that 11.3% of the unique S proteins from Oceania possessed 42.58% mutations. We collected 204440 Spike protein sequences from (NCBI and GAISED databases). Upon filtering, 191536 redundant sequences were removed and 12904 unique sequences (corresponding to 6.31% of the initial number of sequences) were selected for phylogenetic analysis. The resultant phylogeny for unique amino acid sequences from SARS-CoV-2 S-protein, revealed a tree with polyphyletic groups, as well as showing sequences from different countries grouping together in the same clade (See Supplementary Figure 1 ). On the other hand, after the Archaepteryx analysis it was identified five predominant sequence groups between different spike variants from different countries ( Figure 1 ). Figure 1 : SARS-CoV-2 spike amino acid phylogeny after group clustering. After Archeopteryx analysis it can be identified five groups: yellow, blue, magenta, green and black. In this case, it can be verified that the different group colors are formed by sequences from J o u r n a l P r e -p r o o f the same continents, but it was identified that grouped sequences from different continent together. Then, after these analyses it could be possible to assume that we have at least five unique SARS-CoV-2 spike variants indicating possibilities for new ways for most specific vaccination and drug development. Additional information on the variability of the amino compositions of the unique Sproteins from each continent relative to the composition of original S-protein from Wuhan was retrieved using the web-based tool Composition Profiler (http://www.cprofiler.org/ ). Results of this analysis are shown in Figure 2A , which clearly shows the presence of some noticeable amino acid composition variability among unique S-proteins from different continents. Since individual S proteins are different from each other and from the original S-protein mostly in very limited number of residues, the range of changes in the normalized enrichment/depletion of a given residue is rather limited (compare scales of Y axis in Figures 2A and 2B , where a composition profile of the intrinsically disordered proteins is shown for comparison). On an average, unique S-proteins form Oceania were found to have the most variability in terms of normalized amino acid composition. This was followed by the unique S-proteins from North America. Curiously, Figure 2A shows that although the normalized content of individual residues in the unique S-proteins from Oceania is always below that of the original S-protein, S-proteins from other continents might have relative excess of some residues. For example, some unique S-proteins from almost all continents can be enriched in glycine or J o u r n a l P r e -p r o o f histidine residues, whereas some European S-proteins can also be relatively enriched in cysteine, isoleucine, tyrosine, phenylalanine, and lysine residues (see positive green bars in Figure 2A ). Another interesting observation is that the different sets of S-proteins are typically characterized by rather noticeable variability of the normalized content of most residues. The noticeable exception is given by aspartate, depletion in which is almost uniform between all the unique S-proteins from all the continents. Next, we looked at the correlation between the frequencies of the mutations in unique S proteins from different locations and intrinsic disorder predisposition of this protein. Figure 3A shows distribution of frequency of mutations within the amino acid sequence of this protein. It is seen that almost each residue of has at least one mutation in different variants currently found in the globe. In fact, only 15 residues (Met 1 , Leu 996 , Ile 997 , Gly 999 , Leu 1001 , Tyr 1 007, Val 1 008, Gln 1010 , Ile 1013 , Arg 1019 , His 1049 , Gln 1054 , Thr 1105 , Asn 1119 , and Leu 1270 ) of the 1273-residue long S protein were never mutated as of the time of this analysis. Curiously, nine of these never-changed residues are concentrated within the short region (residues 996-1019). Figure 3A also shows that mutation frequencies are unevenly distributed within the amino acid sequence of S protein and that the region (residues 675-691) surrounding the furin cleavage site (residues 680-686) seems to be characterized by high mutation frequency. In fact, although the average per-residue frequency of mutations of the entire protein is equal to 4.6, the mutation frequency of the 675-691 region is two-fold higher (9.2). Comparison of the mutation frequency profile ( Figure 3A ) with the per-residue intrinsic disorder predisposition profile generated for the original (Wuhan) version of S-protein by a set of commonly used disorder predictors ( Figure 3B ) indicates that there is some weak correlation between these two parameters, with regions showing more disorder typically undergoing more frequent mutations. Again, Figure 3B shows that region containing furin cleavage site is among the most disordered segments of the S protein (if not the most disordered one). Here, dependencies of the mutation frequencies on the corresponding disorder score evaluated by PONDR ® VSL2 are shown for six geo-locations. In Africa, S protein has 902, 296, 60, 11, and 4 residues with 0, 1, 2, 3, and 4 mutations, which are characterized by the mean disorder scores of 0.27 ± 0.15, 0.28 ± 0.16, 0.30 ± 0.18, 0.29 ± 0.18, and 0.40 ± 0.19, respectively. In Asia, 694, 437, 111, 27, 3, and 1 residues of S protein with 0, 1, 2, 3, 4, and 5 mutations are characterized by the mean disorder scores of 0.26 ± 0.14, 0.28 ± 0.15, 0.32 ± 0. 16 The most frequently mutated residue is Tyr 248 (13 mutations) followed by Val 213 and Thr 108 with 12 and 10 mutations, respectively, all three from unique S protein variants found in North America. This analysis shows that here is a general trend, where residues with higher disorder levels are mutated more frequently. We quantitatively determined the variations in the unique S proteins on six continents. The variations were captured through the frequency distribution of amino acids present, Shannon entropy (amount of conservation of amino acids in a given sequence), and molecular weights and isoelectric points of a given protein sequence. The frequency of each amino acid was computed for each unique S protein available in six continents (Supplementary file-2 ). Maximum and minimum frequencies of amino acids present in the unique S proteins from different continents are presented in Table 4 . Table 4 ). The widest variation in frequency distributions of the twenty amino acids over the unique S proteins was found in North America. To obtain quantitative variations in the unique S proteins available in each continent, differences between maximum and minimum vectors (20 dimensions) were obtained (Table 5) , and then Euclidean distances between the difference vectors was calculated (Table 6 ). Based on the distance matrix, a phylogenetic relationship was derived among the continents ( Figure 2 ). Variations based on the frequency distribution of amino acids present in the S proteins make North America (which belongs to the rightmost branch of the tree) distant from the other five continents (Figure 2 ). Variations among the unique spike proteins from Asia and Oceania turned out to be similar, and they belong to the same level of leaves of the far left branch of the tree. Africa and Europe were found to be the closest in terms of variations based on the frequency distribution of amino acids over the unique spike proteins from each continent. Variability of spike proteins from South America has distant resemblance to that of Africa/Europe as estimated in the phylogeny. The frequencies of amino acid distribution in each unique S protein from each continent are presented in Figures 6 and 7 (See Appendix ). The widest variations of the frequency distribution of amino acids present in S proteins were observed in North America as wide band was observed in Figure 7 . Individual frequency distributions of amino acids in Asia and Oceania seem very close as it was observed from the phylogeny ( Figure 5 ). In principle, for a random amino acid sequence, the Shannon entropy (SE) is one. Here Shannon entropy for each S protein sequence was computed using the formula stated in section 2.2 (Supplementary file-2) . It was found that the highest and lowest SEs of S proteins from all continents were 0.9643 and 0.9594 respectively. That is, the length of the largest interval is 0.005 which is sufficiently small. Also note that the length of the smallest interval was 0.001 which occurred in the SEs of S proteins from South America. Within this realm, the widest variation of SEs was noticed among the unique S proteins of North America. All other four intervals (considering lowest and highest) of SEs of all the unique S proteins from four continents Africa, Asia, Oceania and Europe were contained in the interval of North America and contain that of South America. Among all (20 1273 ) possible amino acids (20 in number) sequences of length 1273, Nature(?) had selected only a fraction to make S proteins of SARS-CoV-2, and interestingly SEs of them were kept within a very small interval. From the SEs which were close to 1, the S protein sequences are expected to be pseudo-random. Variation of SEs for all unique S proteins from each continent is shown in Figures 5 and 6 (See Appendix ) . Conservation of amino acids present over each S protein from each continent is different from one another which is depicted by the zig-zag nature of SEs plots (Figure 8 and 9 ). For each S protein sequence from each continent isoelectric point (pI) was computed (Supplementary file-3). Intervals (considering minimum and maximum) pIs of unique spike proteins from each continent were tabulated in Table 8 . It was noticed that pIs for all the unique S proteins from the six continents were distributed between 5.61 and 7.79. The largest interval of pIs was found for the unique S proteins from North America. Therefore, the widest varieties of unique S proteins were found in North America. The degree of non-linearity of the plots of pIs for each protein from each continent shows wide variations of unique S proteins ( Figures 10 and 11 (See Appendix ) ). Various mutations in S proteins lead to the evolution of new variants of SARS-CoV-2 [43] . Naturally, our attention was captured to characterize unique S protein variants which were embedded in SARS-CoV-2 genomes infecting millions people worldwide [44] . As of May 7, 2021, there are 127760 patients infected with SARS-CoV-2 with 16143 S protein variants, which undoubtedly well-organized by means of amino acids composition and conservation as it was depicted by Shannon entropy and isoelectric point. Among the unique spike proteins present in a continent, many of them are common in other continents as well ( Table 2) . On the other hand, there are still a handful of unique spike protein variants residing in each continent. Considering the nature and biological implications of the new variants of SARS-CoV-2 caused by different mutations in S proteins, the appearance of several unique S variants in SARS-CoV-2 is certainly a worrying event. [45] . There are still many unique S protein variants in all continents that may spread from person to person through close communities or by spontaneous mutations causing a condition that may become alarming. Comparative analysis revealed the presence of some weak correlation between the perresidue mutability and intrinsic disorder predisposition of S protein, with residues possessing higher disorder predisposition typically showing higher mutation rates as well. For example, the J o u r n a l P r e -p r o o f mean disorder score of 89 residues that were mutated 10-18 times is 0.35 ± 0.18 as compared to the mean disorder score of 0.26 ± 0.12 for 155 residues with 0 and 1 mutations. Curiously, the most disorder region of the S protein (residues 675-691), which includes the furin cleavage site (residues 680-686), was shown to be characterized by high mutation frequency, with Pro 681 (which was mutated 17 times) being second most frequently mutated residue of this protein. We observed that unique S proteins from North America have mutations in almost every amino acid residue position (1184 out of 1273), while unique spike variants from the other continents only have mutations in 16 to 20% of residues. So, even if international travel is limited, S proteins from these five continents will likely acquire mutations at other residue positions where mutations have already been found in the specific variants from North America due to natural evolution. Based on the amino acid frequency distributions in the S protein variants from all the continents, a phylogenetic relationship among the continents was drawn. The phylogenetic relationship implies that unique S proteins from North America were found to be significantly different from that of other five continents. Therefore, the possibility of spreading the unique variants originated from North America to the other geographic locations by means of international travel is high, and numerous mutations have been detected already in the unique variants from North America. Of note, South America infection/herd immunity status may have summarized by Manaus city example (the capital of Amazonas state in northern Brazil) where by June 2020 to October 2020 SARS-CoV-2 prevalence among Manaus population increased from ~60% to ~70%, a condition which may mirror acquisition of herd immunity [46] . By January 2021 Manaus had a huge resurgence in cases due to emergence of a new variant known as P.1, which was responsible for nearly 100% of the new case [47] . Although the population may have then reached a high herd immunity threshold, there is still a risk of resurgence of new immunity-escape variants, which raises important questions. For example, 1. Is post-infection herd immunity not enough for protection and should it be combined with vaccination? 2. Will the crucial viral variants (mutations) be listed by WHO and recommended to be included in "next generation vaccines"? [48, 49] . In addition, we cannot yet exclude the possibility of serious mutations in the viral RBD emerging in India and the USA [48] . Let us have a brief glance at the potential consequences of the mutations in S-protein from the viewpoint of protective immunity towards SARS-CoV-2. It is known that the protective immunity towards infection and disease depends on the presence of high avidity antibodies. This is because high avidity of neutralizing antibodies, which is defined as the strength of antibody-target epitope interaction, plays an important role in antibody-mediated protection against viral infections [12] . High avidity (functional affinity) is established during affinity maturation, as the avidity of IgG is low during acute infection and reaches high values several weeks or months later [50, 51] . Importantly, incomplete avidity maturation of IgG directed towards the often leads to the failure of the protection against viral infections and/or resultant diseases, as was shown for varicella zoster virus (VZV), cytomegalovirus (CMV), the measles virus, Dengue virus, the respiratory syncytial virus (RSV), Simian human immunodeficiency virus (SHIDV) [52, 53, 54, 55, 56, 57, 58, 59] . Since the interaction between the receptor-binding domain of SARS-CoV-2 spike protein and angiotensinconverting enzyme-2 (ACE2) on target cells is characterized by high affinity, it is expected that the protective anti-SARS-CoV-2 antibodies should possess high affinity/avidity to be able to block this high affinity RBD-ACE2 interaction [11] . Recently, it was shown that the serological response to SARS-CoV-2 is frequently characterized by the incomplete maturation of avidity [60, 50] . It was also proposed that such incomplete avidity maturation represents an essential strategy of coronaviruses determining high probability of repeated J o u r n a l P r e -p r o o f waves of reinfections with these viruses due to the short-lasting protective immunity [61, 62, 12] . Furthermore, an unexpected scenario was recently uncovered, where the natural SARS-CoV-2 infection does not lead to the establishment of a high avidity immune response and therefore does not have a good chance for the development of complete protection against SARS-CoV-2 and for establishment of herd immunity [63] . On the contrary, complete avidity maturation was achieved with two rounds of vaccination, whereas the quality of the immune response after natural infection was similar to that generated by one vaccination step and did not reach the quality of complete vaccination with two steps. Therefore, the scenario occurring in Manaus city can be considered on the basis of these new findings. In fact, it is obvious now that despite the high COVID-19 prevalence reached in this city, no herd immunity could be expected retrospectively, as natural infection is insufficient for the establishment of a high avidity immune response and related development of complete protection against SARS-CoV-2 [63] . Therefore, it seems likely that the herd immunity can only be reached through at least two vaccination steps [63] . It is also expected that the herd immunity might be partially or completely overrun by the novel SARS-CoV-2 variants showing higher affinity of RBD-ACE2 interaction that that of the originally infecting variant. Hence in the near future, we can expect to experience more new SARS-CoV-2 variants which might cause third, fourth, and fifth etc. waves of COVID-19. Therefore, massive vaccination is necessary to combat COVID-19, and of course, existing vaccines must be reviewed, and if needed further re-engineered may be required based on newly emerging S protein variants. Altogether, data presented in this study indicate that although unique variants of the SARS-CoV-2 S protein are rather abundant, they are unevenly distributed among continents, with Africa possessing highest percentage of unique S variants, and with unique S proteins found in North America being noticeably different from the variants seeing on other continents. It is likely that these unique variants can spread to continents where they have not been detected before. Furthermore, this inhomogeneity raises an important question on why the currently observed difference in the number of unique variants of S protein (reflecting frequency of its mutagenesis) is so great. It cannot be easily explained by the differences between the continents in the number of COVID-19 patients (reported SARS-CoV-2-positive cases). In fact, according to Worldometer, as of September 10, 2021, there were 8,087,058, 72,407,564, 56,618,705, 181,742, 50,106,216, and 37,213 ,429 recorded COVID-19 cases in Africa, Asia, Europe, Oceania, North America, and South America, respectively. Obviously, these infection levels do not correlate with the corresponding numbers of unique S protein variants (see Tables 1 and 2 ). There is also no strong correlation between the reported S protein variability and levels of genomic sequencing in different continents (which serves now as a real-time molecular/genomic SARS-CoV-2 surveillance). In fact, it was reported recently that as of 5 July 2021, 25,284 whole-genome sequences from Africa (0.32% of all reported SARS-CoV-2-positive cases from that continent), 146,562 from Asia (0.30% coverage), 1,292,415 from Europe (2.35% coverage), 692,704 from North America (1.75% coverage), 37,913 from South America (0.12% coverage) and 20,613 from Oceania (25% coverage) had been generated [64] . Therefore, although these numbers reflecting levels of the continent-wise coverage show a heavy bias toward the regions and countries with more specialized genomic facilities, programs, and research projects, there is no strong correlation between the coverage and established S-protein variability [65, 66] . An intriguing possible mechanism of the observed differences in the rates of virus evolution is the presence of a conceivable variability of the ACE2 gene in different continents that might have an impact on the variability of the viral protein as well. In line with this idea, Table 12 : List of spike proteins from Asia, which were found to be identical with spike proteins from other five continents A1 A71 A115 A171 A207 A239 A280 A344 A388 A8 A76 A121 A173 A210 A244 A282 A345 A391 A12 A77 A122 A174 A211 A245 A283 A348 A394 A14 A78 A126 A175 A212 A247 A284 A351 A395 A15 A85 A127 A177 A213 A249 A286 A354 A396 A19 A89 A128 A178 A214 A253 A291 A356 A399 A23 A90 A133 A180 A215 A254 A292 A357 A401 A26 A91 A134 A181 A216 A255 A293 A358 A404 A28 A93 A135 A182 A217 A257 A304 A359 A405 A30 A95 A138 A183 A218 A258 A305 A360 A408 A31 A96 A140 A191 A219 A264 A322 A367 A413 A32 A97 A142 A193 A221 A265 A323 A373 A418 A33 A100 A148 A195 A222 A267 A324 A375 A419 A34 A101 A158 A196 A223 A273 A325 A378 A430 A36 A102 A159 A198 A224 A274 A333 A379 A431 A43 A103 A161 A199 A230 A275 A335 A380 A44 A105 A163 A200 A233 A276 A340 A381 A58 A109 A164 A201 A234 A277 A341 A383 A67 A111 A166 A205 A235 A278 A342 A386 J o u r n a l P r e -p r o o f Journal Pre-proof A69 A114 A170 A206 A238 A279 A343 A387 Spike proteins (Asia) which were found to be identical with spike proteins from other five continents Table 13 : List of spike proteins from Africa, which were found to be identical with spike proteins from other five continents AF1 AF34 AF58 AF79 AF101 AF117 AF128 AF145 AF156 AF227 AF263 AF2 AF38 AF64 AF82 AF103 AF118 AF130 AF146 AF165 AF229 AF268 AF3 AF46 AF69 AF83 AF104 AF119 AF131 AF147 AF168 AF230 AF271 AF8 AF47 AF71 AF88 AF105 AF120 AF133 AF149 AF179 AF231 AF278 AF9 AF48 AF72 AF90 AF108 AF121 AF134 AF151 AF195 AF247 AF283 AF19 AF50 AF73 AF92 AF114 AF123 AF137 AF152 AF196 AF248 AF31 AF51 AF76 AF99 AF115 AF125 AF138 AF154 AF223 AF254 Table 15 : List of spike proteins from North America, which were found to be identical with spike proteins from other five continents NA7 NA391 1 NA977 6 NA1336 2 Spike proteins (North America) which were found to be identical with spike proteins from other five continents Table 17 : List of spike proteins from South America, which were found to be identical with spike proteins from other five continents SA1 SA13 SA22 SA29 SA35 SA44 SA66 SA4 SA18 SA25 SA30 SA38 SA45 SA68 SA5 SA19 SA26 SA31 SA41 SA56 SA70 SA7 SA20 SA27 SA32 SA42 SA61 SA71 SA11 SA21 SA28 SA33 SA43 SA63 Similarly, based on the comprehensive analyses of the allelic frequencies of the polymorphisms in the ACE2, TMPRSS2, TMPRSS11A, cathepsin L (CTSL), and elastase (ELANE) genes in populations from the American, African, European, and Asian continents it was concluded that the noncoding sequences of these genes encoding proteins related to the SARS-CoV-2 cell Sarif Hassan: Study design, Formal analysis, Investigation, Methodology, Visualization, Writing -Original Draft Formal analysis, Investigation, Writing -Original Draft Formal analysis, Investigation, Methodology, Visualization, Writing -Review & Editing Formal analysis, Investigation, Methodology, Visualization, Writing -Review & Editing Writing -Review & Editing; Vasco Azevedo: Formal analysis, Investigation, Methodology, Visualization, Writing -Review & Editing Pabitra Pal Choudhury: Formal analysis, Writing -Review & Editing Formal analysis Uhal: Formal analysis, Writing -Review & Editing Formal analysis Formal analysis Formal analysis Formal analysis Formal analysis Aljabali: Formal analysis, Writing -Review & Editing Formal analysis Formal analysis Formal analysis Formal analysis Formal analysis Formal analysis Formal analysis Formal analysis Uversky: Study design, Formal analysis, Methodology, Investigation, Visualization, Writing -Original Draft Exploring the genomic and proteomic variations of sars-cov-2 spike glycoprotein: a computational biology approach, Infection Carbon-based nanomaterials: Promising antiviral agents to combat covid-19 in the microbial resistant era Possible transmission flow of sarscov-2 based on ace2 features Protective face mask filter capable of inactivating sars-cov-2, and methicillinresistant staphylococcus aureus and staphylococcus epidermidis Notable sequence homology of the orf10 protein introspects the architecture of sars-cov-2 A unique view of sars-cov-2 through the lens of orf8 protein Sars-cov-2 spike-protein d614g mutation increases virion spike density and infectivity Human sars cov-2 spike protein mutations Controlling the sars-cov-2 spike glycoprotein conformation The structural basis of accelerated host cell entry by sars-cov-2 Blocking of the high-affinity interaction-synapse between sars-cov-2 spike and human ace2 proteins likely requires multiple high-affinity antibodies: an immune perspective The potential significance of high avidity immunoglobulin g (igg) for protective immunity towards SARS-CoV-2 Emergence in late 2020 of multiple lineages of sars-cov-2 spike protein variants affecting amino acid position Structures and distributions of sars-cov-2 spike proteins on intact virions No evidence for distinct types in the evolution of sars-cov-2 Emergence of genomic diversity and recurrent mutations in sars-cov-2, Infection Structural impact on sars-cov-2 spike protein by d614g substitution Epidemiology, virology, and clinical features of severe acute respiratory syndromecoronavirus-2 (sars-cov-2; coronavirus disease-19) The coronavirus is mutating-does it matter? Tracking changes in sars-cov-2 spike: evidence that d614g increases infectivity of the covid-19 virus Evaluating the effects of sars-cov-2 spike mutation d614g on transmissibility and pathogenicity Sars-cov-2 evolution and vaccines: cause for concern? Emergence of a sars-cov-2 variant of concern with mutations in spike glycoprotein Seqkit: a cross-platform and ultrafast toolkit for fasta/q file manipulation Mega x: molecular evolutionary genetics analysis across computing platforms Muscle: multiple sequence alignment with high accuracy and high throughput phyloxml: Xml for evolutionary biology and comparative genomics Evolution of amino acid frequencies in proteins over deep time: inferred order of introduction of amino acids into the genetic code Composition profiler: a tool for discovery and visualization of amino acid composition differences Disprot: the database of disordered proteins Pathogenetic perspective of missense mutations of orf3a protein of sars-cov-2 Missense mutations in sars-cov2 genomes from Indian patients The shannon information entropy of protein sequences Determination of the isoelectric point of proteins by capillary isoelectric focusing The isoelectric point, a key to understanding a variety of biochemical problems: a minireview The chemistry of the proteins and amino acids Sequence complexity of disordered protein Length-dependent prediction of protein intrinsic disorder Optimizing long intrinsic disorder predictors with protein evolutionary information Pondr-fit: a metapredictor of intrinsically disordered amino acids Iupred2a: context-dependent prediction of protein disorder as a function of redox state and protein binding Critical assessment of protein intrinsic disorder prediction Antibody cocktail to sars-cov-2 spike protein prevents rapid mutational escape seen with individual antibodies Identification of sars-cov-2 spike mutations that attenuate monoclonal and serum antibody neutralization A sars-cov-2 vaccine candidate would likely match all currently circulating variants Three-quarters attack rate of sars-cov-2 in the brazilian amazon during a largely unmitigated epidemic Five reasons why covid herd immunity is probably impossible Will sars-cov-2 variants of concern affect the promise of vaccines? Covid-19 pandemic and vaccination build herd immunity The variability of the serological response to sars-corona virus-2: potential resolution of ambiguity through determination of avidity (functional affinity) Avidity of igg in serodiagnosis of infectious diseases Varicella-zoster virus antibody avidity and igg-subclass patterns in children with recurrent chickenpox Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection Maternal igg avidity and igm detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus Serologic screening of pregnant Korean women for primary human J o u r n a l P r e -p r o o f Journal Pre-proof cytomegalovirus infection using igg avidity test Maternal immunoglobulin g avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans Lack of antibody affinity maturation due to poor toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease Gm-csf DNA: an adjuvant for higher avidity Igg, rectal Iga, and increased protection against the acute phase of a shiv-89.6 p challenge by a DNA/mva immunodeficiency virus vaccine The serological response to SARS corona virus-2 is characterized by frequent incomplete maturation of functional affinity (avidity Seasonal coronavirus protective immunity is short-lasting Direct observation of repeated infections with endemic coronaviruses Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity Igg response versus incomplete avidity maturation WHO-COVID-19-Dashboard, COVID live update Substantial underestimation of SARS-CoV-2 infection in the United States Prevalence of SARS-CoV-2 in Karnataka Ace2 and tmprss2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy Genetic association of ace2 rs2285666 polymorphism with COVID-19 spatial distribution in India Variability in genes related to SARS-CoV-2 entry into host cells (ace2, tmprss2, tmprss11a, elane, and ctsl) and its potential use in association studies